Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 4

Status

Completed 4Unknown 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5

Conditions

Hodgkin Disease 5Lymphoma 4Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Recurrence 1Dermatitis, Contact 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 115fludarabine phosphate 67Mycophenolic Acid 62Etoposide 61Peripheral Blood Stem Cell Transplantation 58Tacrolimus 55Melphalan 48Filgrastim 48Busulfan 48Whole-Body Irradiation 47Doxorubicin 46Radiotherapy 42fludarabine 38Cyclosporine 38Brentuximab Vedotin 38Vinblastine 35Granulocyte Colony-Stimulating Factor 35Antilymphocyte Serum 30Methotrexate 29Dacarbazine 29Gemcitabine 28Rituximab 26Nivolumab 25Prednisone 24Bleomycin 24Vincristine 22pembrolizumab 21Carmustine 21Cytarabine 20thymoglobulin 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Hodgkin Disease × Mechlorethamine × Clear all
NCT00574496 2023-09-28

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
25 enrolled 10 charts
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

NCT00352027 2023-09-22

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

St. Jude Children's Research Hospital

Phase 2 Completed
81 enrolled 81 charts
Lymphoid

Hodgkin Disease

NCT00002715 2020-08-12

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

Stanford University

Phase 2 Completed
50 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00003262 2013-09-20

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

National Cancer Institute (NCI)

Phase 2 Unknown
30 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00002714 2013-05-15

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease

National Cancer Institute (NCI)

Phase 2 Completed
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡